Kane Biotech

company

About

Kane Biotech is a biotechnology company that engages in the research and development of products to prevent and disperse biofilms.

  • 1 - 10

Details

Last Funding Type
Pre-seed
Industries
Biotechnology,Health Care,Medical
Founded date
Jan 1, 2001
Number Of Employee
1 - 10
Operating Status
Active

Kane Biotech Inc., a biotechnology company, engages in the research and development of products to prevent and disperse biofilms in medical and industrial applications. Its products include ALEDEX, an antimicrobial/antibiofilm composition comprising protamine sulfate and chlorhexidine, with applications in anti-infective medical device coatings, animal care and dairy, and food processing industries; DispersinB, an antibiofilm enzyme that inhibits, as well as disperses microbial biofilms, with applications in wound care, medical devices, oral care, and animal healthcare; and a toothpaste and mouthwash additive based on competence stimulating peptide technology for preventing and dispersing dental plaque biofilms. The company was founded in 2001 and is headquartered in Winnipeg, Canada.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$1.48M
Kane Biotech has raised a total of $1.48M in funding over 2 rounds. Their latest funding was raised on Nov 5, 2020 from a Post-IPO Debt round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 5, 2020 Post-IPO Debt $1.48M 1 Detail
Jan 1, 2003 Pre-seed 1 Detail

Investors

Number of Lead Investors
Number of Investors
2
Kane Biotech is funded by 2 investors. Pivot Financial Inc and Genesys Venture are the most recent investors.
Investor Name Lead Investor Funding Round
Pivot Financial Inc Post-IPO Debt
Genesys Venture Pre-seed